The IT @ Networking Awards 2010 - Open Competition for Healthcare IT Solutions

The IT @ Networking Awards 2010 (IT @ 2010) is an open competition for fully implemented, operable healthcare IT solutions. The goal is to raise awareness of some of the world's finest and most innovative local, regional and national healthcare IT projects.

Recognition
High-tech, high-cost medicine; ageing populations; patient mobility and staff shortages are only some of the challenges healthcare providers face today. Intelligent IT solutions increase cost-effectiveness, productivity and safety and help healthcare facilities to confront these problems. IT @ 2010 brings these innovations into the global spotlight and provides them with the recognition and media attention they deserve.

Their stories will inspire others, proving that challenges can be transformed into future opportunities and success stories.

Novel and Interactive
The core aim of IT @ 2010 is to learn from the mistakes and achievements of different top IT installations. Our unique peer-to-peer voting system empowers daily users such as CEOs, CIOs, CMIOs, hospital and IT managers to vote for their preferred projects, as they are best placed to judge the real value of projects.

First Day - MindByte Session
All Nominees will present in the MindByte, a five minute introductory presentation followed by a lively five minute Q&A. The qualifying audience will vote immediately after each presentation according to the voting criteria for their favourite solution.

Becoming a Nominee is a huge achievement and each will be awarded the prestigious IT @ 2010 Nominee Silver Medal.

Second Day - WorkBench Session
The nine top-rated Nominees will progress as Finalists into the next day WorkBench, a 30-minute in-depth presentation followed by a 15 minute Q&A discussion, providing the audience with a thorough understanding of the project. The qualifying audience will vote immediately after each presentation to choose the winners. Finalists will be awarded the prestigious IT @ 2010 Finalist Gold Medal.

The Prize
The top three IT solutions will be awarded a prize.

THE WINNING PROJECT WILL RECEIVE:
The IT @ Networking Awards 2010 Trophy;
A cash prize of € 5,000;
Media promotion in Europe's leading healthcare management media worth € 50,000.

THE 2ND PROJECT WILL RECEIVE:
The IT @ Networking Awards 2010 Trophy;
Media promotion in Europe's leading healthcare management media worth € 25,000.

THE 3RD PROJECT WILL RECEIVE:
The IT @ Networking Awards 2010 Trophy.

How to submit your project?
All entries must already be implemented in at least one site and must be fully operable. All projects must be presented in accordance to the voting criteria. The maximum length of the abstract is 300 words.

For your chance to win, please enter your submission through www.conftool.com/itawards2010

Submission deadline for the Abstract is 25 June 2010.

All project submissions (Abstracts) will be presented to the IT @ 2010 Review Committee. This Review Committee will decide the top 25 IT solutions that will become Nominees and will take part in the MindByte Session.

Submissions without any commercial interest or any link to healthcare service providers are free. All the others are charged a one time registration fee of 1000 EUR.

All nominees are required to submit a 5 minute PowerPoint or Keynote presentation for the first MindByte Session. This is your chance to explain to the audience what differentiates your solution and what makes it special.

Submission deadline for the MindByte Presentation is 31 August 2010.

As a nominee you are also required to submit a 30-minute presentation for the second day WorkBench Session.

Submission deadline for the Workbench Presentation is 20 September 2010.

For further information and registration, please visit:
http://itandnetworking.org

Most Popular Now

Amgen and Allergan's MVASI™ (bevacizumab-awwb) and…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a bio...

Compound found in red wine opens door for new trea…

Like to unwind with a glass of red wine after a stressful day? Don't give alcohol all the credit. New research has revealed that the plant compound resveratrol, which is ...

HIV vaccine nears clinical trial following new fin…

A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar p...

Mylan and Upjohn, a division of Pfizer, to combine…

HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer's o...

Leading oncologists and nutritionists pinpoint are…

An international collaborative led by Ludwig Cancer Research and Cancer Research UK has identified key areas that are central to uncovering the complex relationship betwe...

Closing the door: breaking new ground related to a…

In order to sustain fast growth, cancer cells need to take up nutrients at a faster rate than healthy cells. The human glutamine transporter ASCT2 allows the amino acid g...

FDA approves first generics of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associat...

Roche and Spark Therapeutics, Inc. announce extens…

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") announced that Roche has extended the offering period of its previously announced...

FDA approves first treatment for severe hypoglycem…

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that c...

Rye is healthy, thanks to an interplay of microbes

Eating rye comes with a variety of health benefits. A new study from the University of Eastern Finland now shows that both lactic acid bacteria and gut bacteria contribut...

GSK completes transaction with Pfizer to form new …

The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and Panadol and Pfizer's Advi...

Eating more plant-based foods may be linked to bet…

Eating mostly plant-based foods and fewer animal-based foods may be linked to better heart health and a lower risk of dying from a heart attack, stroke or other cardiovas...